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Symptoms of attention deficit hyperactivity disorder (ADHD) and autistic spectrum disor-
der (ASD) often co-occur. The DSM-IV had specified that an ASD diagnosis is an exclusion
criterion for ADHD, thereby limiting research of this common clinical co-occurrence. As
neurodevelopmental disorders, both ASD and ADHD share some phenotypic similarities,
but are characterized by distinct diagnostic criteria.The present review will examine the fre-
quency and implications of this clinical co-occurrence in children, with an emphasis on the
available data regarding pre-school age.The review will highlight possible etiologies explain-
ing it, and suggest future research directions necessary to enhance our understanding of
both etiology and therapeutic interventions, in light of the new DSM-V criteria, allowing for
a dual diagnosis.
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INTRODUCTION
In the last decade, studies have reported increased prevalence of
both attention deficit hyperactivity disorder (ADHD) and autistic
spectrum disorders (ASD). While ADHD is defined by impaired
functioning in the areas of attention, hyperactivity, and impul-
sivity, whereas ASD is characterized by core social dysfunction
and restrictive-repetitive behaviors, studies show that between 30
and 50% of individuals with ASD manifest ADHD symptoms
(particularly at pre-school age), and similarly, estimates suggest
two-thirds of individuals with ADHD show features of ASD (Davis
and Kollins, 2012). Recent findings from the Autism Treatment
Network (ATN) database suggest that co-occurrence of ADHD
and ASD is associated with a lower quality of life and poorer adap-
tive functioning than in any one of these conditions (Vora and
Sikora, 2011). Both disorders often include difficulties in atten-
tion, communication with peers, impulsivity, and various degrees
of restlessness or hyperactivity. Both are more common in boys
than in girls, and present, at least partially, at pre-school age. Both
disorders have a known genetic pre-disposition, with comorbidity
within the same individual and across family members, and both
syndromes cause significant behavioral, academic, emotional, and
adaptive problems in school, at home, and elsewhere. (Rao and
Landa, 2013).
Evidence for common neurobiological substrates has been
found through similarities in neuropsychological profiles in indi-
viduals with both disorders (Gargaro et al., 2011; Rommelse et al.,
2011). It has been shown that children with ADHD have prag-
matic language difficulties similar to children in the ASD spectrum
(Bishop and Baird, 2001). Further neuropsychological similari-
ties are suggested by a study of emotional recognition and theory
of mind, which showed that children with ADHD could not be
distinguished from those with ASD (Buitelaar et al., 1999). A
study on social perspective taking showed children with ADHD
used lower levels of social perspective taking coordination in their
definition of problems, identification of feelings, and evaluation
of outcomes than children without ADHD, and these differences
persisted after the role of language abilities, intelligence, and oppo-
sitional and conduct problems were taken into account (Marton
et al., 2009).
Despite the growing body of research pointing at the frequent
co-occurrence of these two disorders, the previous DSM-IV-TR
has not allowed a dual diagnosis. The DSM-V, in its revised ADHD
diagnostic criteria, recognizes the frequency of this co-occurrence
and allows, for the first time, a co-morbid diagnosis of ADHD with
autism spectrum disorder. This new attitude will not only allow
for more efficient clinical management of these children, but will
also clear the way for a more precise scientific understanding of
the overlap of these two disorders. While most research to date has
documented developmental trajectories for ADHD and ASD sep-
arately, little is known regarding their co-occurrence, particularly
at young pre-school age. PUBMED was searched using the defin-
ition “co-occurrence of ASD and ADHD in pre-school children.”
This led to only 35 studies, and therefore search was broadened to
include the more general definition of the “co-occurrence of ASD
(or social-communication difficulties) and ADHD in children.”
More than 150 articles were eventually reviewed.
ADHD (SYMPTOMS) IN CHILDRENWITH ASD
A significant percentage of children with ASD seeking services at
clinical centers present with comorbid symptoms of ADHD, with
rates ranging between 37% (Gadow et al., 2006) and 85% (Lee
and Ousley, 2006) across studies conducted in the United States
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and Europe (Rao and Landa, 2013). ADHD was the third most
common disorder identified in a community sample of 5–17 years
old children (Leyfer et al., 2006), with 31% of the sample meeting
full ADHD criteria and another 24% with subsyndromal ADHD
symptoms. This is lower than reported rates of ASD and ADHD
in clinic samples (Rao and Landa, 2013). Very few studies have
looked at the epidemiology of co-existing disorders in pre-school
age children diagnosed with ASD. Two year-old twins (n= 312)
from the Boston University Twin project were studied by Ronald
et al. (2010) for autistic-like traits and ADHD behaviors using
Child Behavior Checklist (CBCL) answered by their parents. Con-
trolling for cognitive abilities and socioeconomic status, autistic
like traits correlated positively with ADHD behaviors (r = 0.23–
0.26), a lower correlation than described for older children. In a
recent survey by Carlsson et al. (2013), 198 pre-school Swedish
children (age 4.5–6.5 years) with ASD who treated in a habilita-
tion center, were assessed for such disorders. They found language
problems in 78%, intellectual disability in 49%, below average
motor function in 37%, and severe hyperactivity in 33%.
Lecavalier et al. (2009) has lately shown the validity of DSM-
IV syndromes in a group of 229 pre-schoolers with ASD, using
confirmatory factor analysis (CFA). Despite very high factor load-
ing with the general ADHD combined factor, several items had
non-significant loadings with the specific ADHD hyperactive–
impulsive factor. In other words, the verbal items from the
hyperactive–impulsive sub scale were negatively correlated with
the other motor items suggesting hyperactivity–impulsivity has
two components: physical and verbal. The authors comment that
this is a good example of how the clinical features of ASD might
alter the clinical presentation of a co-occurring DSM-IV defined
(pre-school) ADHD. In a study by Sikora (Sikora et al., 2012),
as part of the Autism Speaks ATN, data was collected from 14
sites in the US and Canada. Participants between the age of 2
and 17.9 years were included if they met DSM-IV and/or Autism
Diagnostic Intervention Schedule (ADOS) diagnostic criteria for
ASD, if they were cared for at an established ATN site, if parents
was fluent in English, and it was the language spoken with the
child at least 75% of the time. Parents were asked to complete
the CBCL and the pediatric quality of life inventory (PedsQL)
and were also interviewed to complete the Vineland Adaptive
Behavior Scales (VABS-II). Cognitive scores were used as covari-
ates. Of the whole study group, 1737 participants were 2–5 years
old. Of these, 40% had elevated T score in 1 of the 2 ADHD-
related scales, and 18.8% had both ADHD-related scales T scores
(>70) elevated. The ASD+ADHD group had lower scores on
both the VABS-II and the PedsQL. The authors conclude that
over one third of children with ASD have some comorbid ADHD
symptoms, and their presence is related to greater problems in
adaptive skills and poorer overall quality of life, and suggest pri-
mary care providers should screen for symptoms of ADHD in their
patients with ASD, and consider these symptoms when developing
a care plan.
ASD SYMPTOMS (SOCIAL-COMMUNICATION DIFFICULTIES)
IN CHILDRENWITH ADHD
Social problems are not part of the core diagnostic criteria for
ADHD, but children with ADHD experience significant social
difficulties (Cantwell, 1996; Friedman et al., 2003). ADHD chil-
dren are more often rejected by their peers, and have fewer friends
(Hoza et al., 2005; Mikami, 2010). In many cases, these difficulties
are viewed as a direct result of the ADHD core symptoms. Inatten-
tive behaviors may lead a child to miss social cues, impulsiveness
may result in upsetting peers, and hyperactivity hinders participa-
tion in organized activities and leads to avoidance of peers. It is
estimated that approximately 50–60% of ADHD children experi-
ence rejection by their peers (Barkley et al., 1990). In fact, many
ADHD children are disliked within minutes of the initial social
interaction (Pelham et al., 1985) and then denied further oppor-
tunities to practice social skills, which lead to further rejection
(Milich et al., 1982). Specific play behaviors have been linked with
rejection of ADHD children and include being bossy, intrusive,
inflexible, controlling, annoying, explosive, argumentative, easily
frustrated, inattentive during organized sports/games, and vio-
lating the rules of the game (Pelham et al., 1985; Whalen et al.,
1985; Klassen et al., 2004; Young et al., 2005). Social functioning
by ADHD subtype varies somewhat according to rater (e.g., teach-
ers, parents, and peers); however, the general consensus is that all
ADHD subtypes are at risk for peer rejection (Carlson and Mann,
2000; Hodgens et al., 2000). The presence of co-morbid psychi-
atric disorders tends to exacerbate social impairments in children
with ADHD (Greene et al., 1996; Antshel and Remer, 2003). This
is significant when considering that over 2/3 of individuals with
ADHD have a co-morbid psychiatric disorder (Cantwell, 1996)
with rates reported to be 15–75% with mood disorder, 25% with
anxiety, and 30–50% with conduct disorder (CD). Others (Bieder-
man et al., 1991; Eiraldi et al., 2000) have found that anxiety and
depression together accounted for 30% of the variance in social
impairment in ADHD. Children with both ADHD and a learn-
ing disability have also been found to have greater peer relations
difficulties than children with only a learning disability (Flicek,
1992).
This profile of social difficulties differs, however, from that
observed in ASD, in which impairment in the basic understanding
of social realm is central, such as a lack of emotional reciprocity
and engagement with others, and the low interest or enjoyment in
social interaction. Cantwell (1996) described a type of social dif-
ficulty in ADHD by a “lack of savoir faire,” and estimated that this
social naivety may affect some 20% of ADHD children and adoles-
cents. Recent research suggests that many individuals with ADHD
may experience social impairments that are more consistent with
those observed in ASD. In children with a primary diagnosis of
ADHD, the level of autistic symptomatology corresponded to the
severity of ADHD subtype; children with the combined type of
ADHD-demonstrated the most autistic symptoms (Reiersen et al.,
2007). In a study recently published by Kotte et al. (2013), a posi-
tive autistic traits (AT) profile operationalized from the CBCL, was
significantly overrepresented among ADHD children vs. controls
(18 vs. 0.87%; P < 0.001).
Recent research suggests many individuals with ADHD may
experience social impairments consistent with those observed
in ASD. Santosh and Mijovic (2004) characterized the social
impairments in children with ADHD as associated with either
relationship difficulty (conduct and affective problems), or with
social-communication difficulty. Children with the latter were
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more likely to exhibit repetitive behaviors, speech and language
impairment, and developmental problems similar to ASD. Other
investigators have described deficient empathy and facial affect
recognition in children with ADHD (Sinzig et al., 2008; Ueker-
mann et al., 2010). Other studies have also pointed at the increased
rate of autistic symptoms in samples of children with ADHD.
Grzadzinski et al. (2011) confirmed the presence of a sub group
of children with ADHD and elevated ratings of core ASD traits
not accounted for by ADHD or behavioral symptoms. The ADHD
group with AT revealed greater ODD behaviors than those with
ADHD-only. Most of the studies conducted in middle or late child-
hood have shown that a substantial proportion of children with
ADHD show significant autistic symptoms (Santosh and Mijovic,
2004; Holtmann et al., 2007; Nijmeijer et al., 2008). Very few stud-
ies have looked at pre-school children with ADHD, in an effort
to identify early “comorbid” ASD symptoms, perhaps because an
ASD diagnosis is usually made at pre-school age, while a pri-
mary ADHD diagnosis is often delayed to late pre-school or early
school age.
IMPACT OF COMORBID ADHD AND ASD
Diagnostic constraints have limited research on co-occurring
ADHD and ASD, because many studies, in accordance with the
DSM-IV, have excluded individuals with other psychiatric or
developmental difficulties (Davis and Kollins, 2012). There is pre-
liminary evidence that when ADHD is comorbid with ASD, the risk
for increased severity of psychosocial problems increases (Gadow
et al., 2004; Yerys et al., 2009). Research comparing individuals
with both diagnoses to individuals with a single diagnosis suggest
that co-occurring symptoms are associated with greater impair-
ment than a single diagnosis. By both parent and teacher reports
children with ADHD and ASD (Rao and Landa, 2013) experience
more difficulty in daily life. Furthermore, these co-occurring con-
ditions may be less responsive to standard treatments for either
disorder. Children 4–8 years old with ASD, whose parents report
significant symptoms of ADHD, show lower cognitive function-
ing, more severe social impairment, and greater delays in adaptive
functioning than children with ASD-only.
Sikora et al. as part of the activities of the ATN (Sikora et al.,
2012) collected data on children with ASD across 14 sites in the
US and Canada. Children were between ages 2 and 17.9 years.
They were divided into groups based on whether their parents
rated them as having clinically significant scores on ADHD prob-
lems subscales from the CBCL. 56.6% of the sample was young
children between 2 and 5 years. Analysis revealed that those with
ASD+ADHD symptoms had lower scores in all the areas mea-
sured. Psychosocial health summary, school functioning, physical
functioning, emotional, and social functioning scores were all
lower than those of the children with ASD alone (P < 0.0001). In
another study by Gadow et al. (2004), PDD and non-PDD clinic
groups showed equally severe ADHD and oppositional defiant
disorder symptoms. As measured by parent and teacher refer-
enced rating scale (ECI-4), Mulligan et al. (2009) compared autism
symptoms in 821 ADHD probands, 1050 siblings, and 149 controls
by using the Social-Communication Questionnaire (SCQ). Latent
class analysis yielded five classes; class 1 (31%) had very few autism
symptoms and low comorbidity; classes 2–4 were intermediate;
class 5 (7%) had high autism symptoms and comorbidity. The
cluster with the highest mean SCQ score (class 5) had the high-
est prevalence of co-morbid oppositional defiant disorder, CD,
language disorder, and motor disorder. Other evidence supports
more ODD symptoms in children with both disorders when using
teacher rating rather than parent ratings (Guttmann-Steinmetz
et al., 2009). These findings, however, describe mostly school age
children, while there is a lack of psychiatric comorbidity studies in
younger children with both conditions.
Several investigators have found (Sinzig et al., 2008; Rao
and Landa, 2013) a higher percentage of children with both
ASD+ADHD were classified as having significant cognitive delays
than children with ASD-only (61 vs. 25%). Kotte et al. (2013)
had reported ADHD children with high score on the AT pro-
file of the CBCL, were significantly more impaired than control
subjects in psychopathology, interpersonal, school, family, and
cognitive domains. Yerys et al. (2009) reported on elevated rates of
externalizing problem behaviors as well as greater impairment in
executive functioning in children with comorbid ASD and ADHD,
compared with children with ASD-only. Children with high func-
tioning autism (HFA) and attention problems scored significantly
below the children with HFA only, on the verbal memory and
delayed recall measures, supporting the proposition that children
with both disorders differ not only on a clinical level but also on a
neurocognitive level (Andersen et al., 2013).
Only one study has looked at the relationship between the two
disorders as they develop over time. St Pourcain et al. (2011)
have followed 5,383 singletons (the Avon Longitudinal Study
of Parents and Children-ALSPAC) ages 4–17 years and assessed
multiple measures of hyperactive–inattentive traits and autistic
social-communication impairment at multiple time points. Autis-
tic symptoms were more stable than those of ADHD behaviors,
which showed greater variability. Trajectories for both traits were
strongly, but not reciprocally interlinked, such that the majority
of children with a persistent hyperactive–inattentive symptoma-
tology also showed persistent social-communication deficits, but
not vice versa. Shared predictors, especially for trajectories of
persistent impairment were maternal smoking during the first
trimester, which included familial effects and a teenage pregnancy.
The authors conclude that patterns of association between ASD
and ADHD symptoms change over time, and propose to remove
exclusivity criteria for these diagnoses in the DSM-V, as has already
been done.
POSSIBLE ETIOLOGIES FOR THE CO-OCCURRENCE OF ASD
AND ADHD
Due to the previous DSM-IV diagnostic constraints, research con-
cerning the possible etiologies of the co-occurrence of ADHD and
ASD is scarce. The central focus of available research is in the fields
of neuropsychology, genetics, and neuroimaging.
Although there are some important differences between the
two disorders, as mentioned in the introduction, ASD and ADHD
share many similar impairments in developmental and cognitive
domains. Both are more common in males, have a strong comor-
bidity with intellectual disability, and are also associated with other
specific learning and developmental difficulties, notably language,
reading, and motor problems. Executive functions (EF) deficits
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are common in both disorders, together with response inhibi-
tion deficit. EF measures hardly discriminated between ADHD
and HFA, but compared to children with ADHD, the HFA group
showed more difficulty with cognitive flexibility and planning
(Cooper et al., 2014). Children with ADHD have pragmatic
language difficulties similar to children in the ASD spectrum
(Bishop and Baird, 2001). Further neuropsychological similari-
ties are suggested by a study of emotional recognition and theory
of mind which showed that children with ADHD could not be
distinguished from those with ASD (Buitelaar et al., 1999).
Rommelse et al. (2010) suggest a variety of hypotheses to
explain co-occurrence, but the two most likely explanations may
be that the two are independent disorders occurring together by
association with a third independent factor, or alternatively they
share a common underlying etiology. The authors believe the latter
is the most likely model and that both disorders share a common
genetic basis. Their view is supported by several family, twin, and
molecular genetic studies. Both family (Holtmann et al., 2007;
Guttmann-Steinmetz et al., 2009) and twin studies (Reiersen et al.,
2007; Ronald et al., 2010) provide support for the hypothesis that
ADHD and ASD originate from partly similar familial/genetic fac-
tors. About 50–72% of the contributing genetic factors in both
disorders show overlap. These shared genetic and neurobiological
underpinnings form an explanation why both disorders occur so
frequently within the same patient and family.
Two related family studies originating from the IMAGE (Holt-
mann et al., 2007; Guttmann-Steinmetz et al., 2009) cohort have
examined the rates and severity of ASD in probands with ADHD
and their siblings. Mulligan et al. (2009) measured autism symp-
toms using the SCQ and compared 821 ADHD probands, 1050
siblings, and 149 controls. Affected and unaffected male (but not
female) siblings had higher ASQ scores than controls. The pheno-
typic correlation between ASD and ADHD was slightly higher for
males (0.63) than for females (0.49). Using a modified method of
the deFries–Fulker analysis, the authors conclude that 56% of the
cross-correlation (=0.18), could be explained by shared genetic
influences on ADHD and ASD. In another study by Nijmeijer
et al. (2008), using the same cohort, 256 sibling pairs and 147
controls were studied, using the Children Social Behavior Ques-
tionnaire (CSBQ). This instrument measures less severe variants
of ASD. Similar to Mulligan’s study, sibling correlations for ASD
were significant, but contrary to the earlier study, correlations were
higher in female probands (0.44), than male probands (0.23). Also,
siblings correlations for ASD were higher in older than younger
children, indicating an increased genetic influence on ASD within
ADHD families over time. In this study, cross correlations were
not significant, suggesting independent familial factors give rise to
ADHD and ASD.
In a twin study, mentioned earlier (Reiersen et al., 2007), AT
were examined in 8 years old ADHD twins (N = 6771), using par-
ent and teacher questionnaires. Phenotypic correlations were 0.54
for parent and 0.51 for teacher data. The authors concluded that
genetic correlations between ASD and ADHD symptoms were all
>0.50. Similar results were reported in a study of young adult twins
(N = 674), using a self reported measures of ADHD and ASD.
A bivariate model indicated that the genetic correlation between
ADHD and ASD was 0.72. Models with additive genetic effects and
unique environmental effects fitted the data best, with no evidence
for sex differences. While the limitation of most of these studies
is the use of rating scales rather than direct clinical measures to
evaluate either ADHD or ASD, together they do point at a genetic
correlation between the two diagnoses.
Linkage studies and Genome Wide Association Studies (GWAS)
have specifically addressed this co-occurrence, pinpointing to
some promising pleiotropic genes, loci, and single nucleotide poly-
morphisms (SNPs). Their authors comment that there is an urgent
need for better designed and powered studies to tackle this com-
plex issue. A recent study (Cross-Disorder Group of the Psychiatric
Genomics Consortium, 2013) using GWAS data from the Psychi-
atric Genomic Consortium (PGC), for cases and controls in five
psychiatric disorders including ADHD and ASD, did not find any
significant genetic correlation between ASD and ADHD, using
common SNP’s. Analyses revealed that there were modest shared
genetic influences between ADHD and AT as well as some com-
mon environmental influences explaining their co-variability. The
contribution of assortative mating and parent-of-origin effects to
the co-occurrence of ASD and ADHD has been investigated by van
Steijn et al. (2012) in 121 families with at least one child diagnosed
with ASD, and one or more biological sibling. All children and par-
ents were carefully screened for the presence of ASD and ADHD.
The authors concluded that cross-assortative mating for ASD or
ADHD does not explain the frequent co-occurrence of these disor-
ders within families. They did show, however, that parental ADHD
is predictive of offspring’ ASD but not vice versa, hinting that risk
factors underlying ASD may overlap to a larger degree with risk
factors underlying ADHD than vice versa.
In autism, as opposed to ADHD, anatomical studies found
larger total brain and white matter volumes in most cortical
brain regions and in the cerebellum, caudate, and globus pallidum
(Piven et al., 1996). A shared anatomical dysmorphology between
the two disorders appears to be a smaller corpus callosum. In func-
tional neuroimaging, the most consistent findings has been that of
reduced frontal and parietal activation across a wide range of tasks
in ASD (Baron-Cohen et al., 1999), which may not be different
for ADHD. Geurts et al. (2013) tested whether there is a relation-
ship between gray matter (GM) volume and autism and ADHD
symptom severity by using structural MRI. They found that self-
reports on symptom severity of both disorders correlated with GM
volume in the left inferior frontal gyrus, but each disorder symp-
tom severity was correlated separately with different cortical areas.
They conclude it seems to be an oversimplification to typify psychi-
atric disorders solely as extremes of brain structure abnormalities.
Di Martino et al. (2013) used voxel wise network centrality, func-
tional connectivity metrics indexing local [degree centrality (DC)]
and global (eigenvector centrality) functional relationships across
the entire brain connectome, in resting state functional magnetic
resonance imaging data from 56 children with ASD, 45 children
with ADHD, and 50 typically developing children. In both clinical
groups, cortical and sub cortical areas exhibited centrality abnor-
malities, some common to both disorders (in the precuneus),
but others were disorder-specific. Secondary analyses differenti-
ating children with ASD into those with or without ADHD-like
comorbidity [ASD(+) and ASD(−), respectively] revealed that
the ASD(+) group shared ADHD-specific abnormalities in basal
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ganglia. By contrast, centrality increases in temporolimbic areas
characterized children with ASD regardless of ADHD-like comor-
bidity. The authors conclude that their work provides evidence for
both shared and distinct underlying mechanisms at the large-scale
network level. These and other neuroimaging studies in the future
might lead to better understanding of the neuro-circuitry involved
in the co-occurrence of ASD and ADHD.
TREATMENT OF CO-OCCURRING ADHD AND ASD
Much evidence supports the use of medications to treat symptoms
of ADHD in typically developing school age children (Subcom-
mittee on Attention Deficit/Hyperactivity Disorder et al., 2011).
ADHD medications have shown their efficacy in pre-school chil-
dren (PATS study), but with less efficacy and more side effects
than in school age children (Riddle et al., 2013). For ASD, med-
ications target comorbid behavioral symptoms like irritability,
hyperactivity, and aggression, rather than the core social and
communication deficits. Several medications have demonstrated
the potential to treat repetitive/stereotyped behaviors, but effi-
cacy data has not been strong. Only two medications, to date,
have been formally approved for use in ASD, and they both
target irritability; Risperidone and Aripiprazole (Abilify) (Owen
et al., 2009; Canitano and Scandurra, 2011; Williams et al., 2013).
Despite limited research on the pharmacological treatment in
ASD, there is a significant increase in the use of psychoactive
medications in this group in recent years, in part due to an
increase in the use in ADHD medications in ASD children with
ADHD symptoms. Frazier et al. (2011) have recently used data
on psychotropic medication from the first wave of the National
Longitudinal Transition Study 2, a nationally representative study
of adolescents ages 13–17 in special education, and have shown
that youths with ASD+ADHD had the highest rates of use
(58.2%), followed by youths with ADHD-only (49.0%) and youths
with ASD-only (34.3%). Youths with ASD, both ASD-only and
ASD+ADHD, used medications across a variety of medication
classes, whereas stimulants were dominant among youths with
ADHD-only.
STIMULANT MEDICATIONS
Methylphenidate and atomoxetine (Frazier et al., 2011) are both
typically used to treat ADHD and are also effective in ASD. Santosh
et al. (2006) conducted a retrospective and an open-label prospec-
tive trial to compare response to stimulants (methylphenidate or
dextroamphetamine) between children with ASD and ADHD and
children with ADHD alone, and found no significant differences in
treatment response or side-effect profiles between groups. How-
ever, other studies suggest that response rates of methylphenidate
may differ in ASD as compared to what is reported in typically
developing children with ADHD alone. The National Institute
of Mental Health Collaborative Multisite Multimodal Treatment
Study of Children with ADHD (MTA) (MTA Cooperative Group,
2004) reported response rates of 70–80% as compared to the 49%
reported in the Research Units of Pediatric Psychopharmacology
(RUPP) Autism Network trial of methylphenidate (Arnold et al.,
2012). In terms of tolerability, 18% of subjects in the RUPP trial
withdrew, yet discontinuation rates were quite low in the MTA
study (1.4%). While methylphenidate may improve irritability in
ADHD without ASD, it appears to worsen irritability in some
patients with ASD.
Reduction in ADHD symptoms has been the primary out-
come measure of most studies of co-occurring ADHD and
ASD. A secondary analysis of the RUPP evaluated the effects
of methylphenidate on social-communication skills and self-
regulation in 33 children with ASD. Weekly dedicated observations
over a 4-week period, indicated that methylphenidate use was asso-
ciated with several positive social outcomes; including improved
initiation of joint attention, improved response to bids for joint
attention, and better affective and self-regulation.
NON-STIMULANT MEDICATIONS
In the only controlled study of atomoxetine (Jahromi et al.,
2009), results were significantly better than placebo, but the
sample size was small and only 7 of 16 children (43%) were
considered responders. Overall, both methylphenidate and ato-
moxetine appear to effectively treat ADHD-related symptoms in
ASD (MTA Cooperative Group, 2004; Arnold et al., 2006, 2012;
Posey et al., 2006; Santosh et al., 2006; Jahromi et al., 2009;
Murray, 2010), but atomoxetine demonstrated better tolerabil-
ity than stimulants in individuals with co-occurring ADHD and
ASD. Response rates may, however, be lower in ASD plus ADHD,
than in ADHD alone, and symptoms of inattention may be less
likely to respond than symptoms of hyperactivity and impulsiv-
ity. Atomoxetine effectiveness may vary as a function of level of
impairment, measured by cognitive ability or by ASD symptom
severity (Arnold et al., 2006; Posey et al., 2006). Finally, treat-
ment success may be limited by tolerability. Many studies have
demonstrated efficacy for antipsychotics, and since the RUPP
trial with risperidone this medication in particular has consis-
tently shown benefit for hyperactivity in ASD (Murray, 2010;
Matson et al., 2011; Sharma and Shaw, 2012). In 2006, The United
States Food and Drug Administration approved risperidone for
the treatment of irritability in ASD in children and adolescents
5–16 years of age. However, significant concerns about tolera-
bility remain and suggest that benefits of this medication must
be carefully weighed against the risks. Evidence from controlled
studies of alpha-2 agonists for ADHD-related symptoms in ASD
is inconsistent and response rates are relatively low. Open-label
studies of guanfacine (Intuniv) appear promising but additional
controlled studies are needed. A retrospective analysis (Posey
et al., 2004) of 80 patients indicated reduction in hyperactivity
and inattention among children with ASD and higher cognitive
functioning. Alpha-2 agonists may be a reasonable alternative or
augmentation strategy and have the advantage of being relatively
benign. Amantadine may be considered in the treatment of ASD
but its use for ADHD-related symptoms is not yet supported
by research (Hosenbocus and Chahal, 2013). Other medica-
tions like melatonin, antioxidants, acetylcholinesterase inhibitors,
and naltrexone, are currently considered off-label for ASD, but
further randomized controlled trials are necessary (Rossignol,
2009).
For all medication categories except MPH, no studies are
available on pre-school children.
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PSYCHOSOCIAL INTERVENTIONS
An up to date literature survey on psychosocial interventions
in children with both ADHD and ASD has not revealed any
results. In a comprehensive review on the treatment of these co-
occurring conditions Davis and Kollins (2012) mention that there
are similarities across approaches to treat both disorders. In both,
treatment uses conditioning procedures, which have evolved in
time to draw on a social learning theory (Brookman-Frazee et al.,
2006). Whereas both ADHD and ASD include behaviorally ori-
ented parental intervention, the role of the family is conceptualized
in a different way; for ADHD “parent training” involves teaching
parents to manage the behaviors of their children, in ASD “par-
ent education”places more emphasis on individualized treatments
that provide parents with tools to promote their child’s (social)
skill development. Davis and Kollins suggest that bridging between
these two strategies might benefit those with comorbid disorders.
While many studies have shown the importance of combining
medication and psychosocial interventions (mostly parental edu-
cation) for children with ADHD, there are only a few studies on
the combined medication and behavioral approach in ASD chil-
dren. Aman et al. (2009) primarily targeted frequent tantrums,
self-injury, and aggression in a trial of risperidone treatment and
parent training, but the combined effects on hyperactivity were
also examined. Results indicated that children who received the
combined treatments had lower rates of aggression and greater
reduction in hyperactivity (requiring lower risperidone dose), as
compared with children who received medication only.
Studies on psychosocial interventions in pre-school children
with co-occurring ASD and ADHD are lacking.
SUMMARY AND FUTURE DIRECTIONS
Research specifically focusing on co-occurring ADHD and ASD
has only recently evolved, being previously limited by the DSM-IV
exclusion criteria. What we have so far learned is that both dis-
orders frequently co-occur, and when they do, they cause greater
morbidity, and create a more complicated clinical challenge. The
new DSM-V, allowing for a dual diagnosis, will hopefully facili-
tate research, by eliminating the exclusion of many patients and
allowing the study of broader phenotypes. Most recent research
focuses on etiology and clinical presentations, with less direct work
on treatment and early intervention protocols. Very few studies
have looked at pre-school children presenting with both condi-
tions, on the impact of early intervention in this age group and
its effect on developmental trajectory. Furthermore, many of the
above quoted studies have used parent and/or teacher rating scales
to assess clinical profiles, rather than direct clinical diagnoses of
the two co-existing disorders. In the future, as a dual diagnosis
is “officially” possible, studies using direct clinical assessment of
both comorbid diagnoses are essential.
Future research should tackle two major hypotheses regarding
the frequent co-occurrence of ASD and ADHD. The first is that
ADHD and Autism are distinct, yet overlapping disorders which
may share some common etiology, probably genetic. The second
hypothesis is that the co-occurrence of autistic symptoms and
ADHD “stands alone” as a distinct clinical disorder, with a dis-
tinct etiology, and a different developmental trajectory. These two
hypotheses should be examined by studying the developmental
trajectories in co-occurring ASD and ADHD, by defining common
co-morbidity profiles in both, and by understanding differences
and similarities in social perception, motor functions and lan-
guage, cognition, and EF in each disorder and in the co-occurring
“phenotype.” Defining early “endophenotypes” as suggested by
Rommelse et al. (e.g., heritable vulnerability traits that form a
link between genes and observable symptoms, e.g., neuroimaging,
neuropsychological functions) of both disorders, should serve to
increase the chance of identifying genetic markers for each one
and for both together (Cross-Disorder Group of the Psychiatric
Genomics Consortium, 2013).
In 2010, Gillberg et al. have coined the ESSENCE concept
(Gillberg, 2010) an acronym for early symptomatic syndromes
eliciting neurodevelopmental clinical examinations, pointing to
the fact that major problems in at least one developmental domain
before age 5 years often signals major problems in the same or
overlapping domains years later. They suggest “There is no time
to wait,” implicating intervention should be the main goal, and
not necessarily the categorical diagnosis. They go on to suggest
intervention should be broad, addressing the multiple aspects of
developmental disorders at this young age. Future studies should
focus on early identification and intervention strategies in this
specific “co-morbid” group, with an emphasis on pre-school chil-
dren, using prospective design, even before pathophysiology is
fully understood.
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